SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Smruthi Organics informs about outcome of board meeting

05 May 2025 Evaluate
Smruthi Organics has informed that it enclosed Audited Standalone Financial Results for the Fourth quarter and year ended 31st March, 2025; Audited Balance Sheet as at 31st March, 2025; Audited Cash Flow Statement, for the year ended 31st March 2025; Report issued by the Statutory Auditors of the Company; Gokhale & Sathe, Chartered Accountants, Mumbai (Firm Registration No: 103264W)on the aforesaid Audited Financial Results. Approved payment of dividend at Rs 1.5 per equity share (15 %) on 1,14,46,290 equity shares of Rs 10 each for FY 2024-25. The date of AGM, Book Closure date and record date for purpose of AGM and Dividend will be informed as a separate corporate announcement.

The above information is a part of company’s filings submitted to BSE.

Smruthi Organics Share Price

112.94 -2.15 (-1.87%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×